Levocetirizine in the treatment of allergic diseases

Bibliography

• Hair PI, Scott LJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006;66:973-96
   PubMed Web of Science ®Google Scholar
• Walsh GM. A review of the role of levocetirizine as an effective therapy for allergic disease [review]. Expert Opin Pharmacother 2008;9(5):859-67
   PubMed Web of Science ®Google Scholar
• Patou J, De Smedt H, van Cauwenberge P, Bachert C. Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine. Clin Exp Allergy 2006;36:972-81
   PubMed Web of Science ®Google Scholar
• Wu P, Mitchell S, Walsh GM. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 2005;35:1073-7
   PubMedGoogle Scholar
• Canonica GW, Fumagalli F, Guerra L, et al. Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study Global Allergy and Asthma European Network. Curr Med Res Opin 2008;24(10):2829-39
   PubMedGoogle Scholar
• Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004;114:838-44
   PubMed Web of Science ®Google Scholar
• Simons FE; Early Prevention of Asthma in Atopic Children (EPAAC) Study Group. Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 2007;18(6):535-42
   PubMed Web of Science ®Google Scholar
• Simons FE. Advances in H1-antihistamines. N Engl J Med 2004;351:2203-17
   PubMed Web of Science ®Google Scholar
• Leurs R, Church MK, Taglialatela M. HI-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002;32:489-98
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Canonica GW. Treating the allergic patient: think globally, treat globally. Allergy 2002;57:876-83
   PubMedGoogle Scholar
• Togias A. Systemic cross-talk between the lung and the nose. Am J Respir Crit Care Med 2001;164(5):726-7
   PubMed Web of Science ®Google Scholar
• Togias AG. Systemic immunologic and inflammatory aspects of allergic rhinitis. J Allergy Clin Immunol 2000;106(5 Suppl):S247-50
   Web of Science ®Google Scholar
• Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164(5):858-65
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107(3):469-76
   PubMed Web of Science ®Google Scholar
• Simons FE, Akdis CA. Histamine and antihistamines. In: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Lemanske RF, Simons FER, editors, Middletons allergy principles and practice. 7th edition. St Louis, MO; Mosby, Inc., 2008. p. 1517-47
   Google Scholar
• Walsh GM, Annunziato L, Frossard N, et al. New insights into the second generation antihistamines. Drugs 2001;61:207-36
   PubMed Web of Science ®Google Scholar
• Estelle F, Simons R. H1 antihistamines current status and future directions. WAO J 2008;1(9):145-55
   Google Scholar
• Baiardini I, Braido F, Cauglia S, et al. Sleep disturbances in allergic diseases. Allergy 2006;61:1259-67
   PubMed Web of Science ®Google Scholar
• Lee HW, Lee HW, Park DJ, et al. The effects of fenofenadine at steady-stae on sleep architecture: a study using polysomnography in healthy Korean volunteers. Epert Opin Pharmacother 2008;9:1655-65
   PubMed Web of Science ®Google Scholar
• Day JH. Levocetirizine: a new selective H1 selective antagonist for use in allergic disorders. Drugs Today (Barc) 2004;40:415-21
   PubMedGoogle Scholar
• Gillard M, Van der Perren C, Moguilevsky N, et al. Major role for the carboxylic function of cetirizine and levocetirizine in their binding characteristics to human H1-histamine receptors. Inflamm Res 2002;51:S79-80
   PubMedGoogle Scholar
• Simons FE. Comparative pharmacology of H1 antihistamines: clinical relevance. Am J Med 2002;113:S38-46
   PubMed Web of Science ®Google Scholar
• Dubuske NM. Levocetirizine: the latest treatment option for allergic rhinitis and chronic idiophatic urticaria. Allergy Asthma Proc 2007;28:724-34
   PubMedGoogle Scholar
• Giustizieri ML, Albanesi C, Fluhr J, et al. H1 receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004;114:1176-82
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Cirillo I, Vizzaccaro A, et al. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin Exp Allergy 2004;34:958-64
   PubMed Web of Science ®Google Scholar
• Thomson L, Blaylock MG, Sexton DW. et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002;32(8):1187-92
   Google Scholar
• Thomson L, Blaylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelail cells. Clin Exp Allergy 2002;32:1187-92
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Ying S, Phipps S, et al. Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans. Clin Exp Allergy 2004;34:1276
   PubMed Web of Science ®Google Scholar
• Walsh GM. Second-generation antihistamines in asthma therapy – is there a protective effect? Am J Respir Med 2002;1:27-34
   PubMedGoogle Scholar
• Lee DK, Gray RD, Wilson AM, et al. Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. Br J Clin Pharmacol 2004;58:34-9
   PubMedGoogle Scholar
• Lipworth BJ. Allergic inflammation in the unified airway: start with the nose. Thorax 2000;55:878-81
   PubMed Web of Science ®Google Scholar
• Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006;36:1161-7
   PubMed Web of Science ®Google Scholar
• Frossard N, Strolin-Benedetti M, Purohit A, et al. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Br J Pharmacol 2008;65:172-9
   Google Scholar
• Dhanya NB, Thasleem Z, Rai R, et al. Comparative efficacy of levoceririzine, desloratadine and fexofenadine by histamine wheal suppression test. Indian J Dermatol Venereol Leprol 2008;74(4):361-3
   PubMed Web of Science ®Google Scholar
• Shih MY, Hsu JY, Weng YS, et al. Influence of cetirizine and levocetirizine on two cytokines secretion in human airway epithelial cells. Allergy Asthma Proc 2008;29(5):480-5
   PubMedGoogle Scholar
• Mahmoud F, Arifhodzic N, Haines D, et al. Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis. J Pharmacol Sci 2008;108(2):149-56
   PubMedGoogle Scholar
• Baltes E, Plisnier M, Kaise J, et al. Absorption and disposition of levocetirizina, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam Clin Pharmacol 2001;15:269-77
   PubMed Web of Science ®Google Scholar
• Molimard M, Diquet B, Benedetti MS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol 2004;8:399-411
   Google Scholar
• Simons FER, Simons KJ. H1 anthistamines: current status and future directions. WAO J 2008;1(9):145-55
   Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Buscaglia S, Pesce G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96:971-9
   PubMed Web of Science ®Google Scholar
• Ricca V, Landi M, Ferrero P, et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol 2000;105:54-7
   PubMed Web of Science ®Google Scholar
• Canonica GW, Ciprandi G. Minimal persistent inflammation may be controlled by cetirizine. Ann Allergy Asthma Immunol 1999;83:445-8
   PubMedGoogle Scholar
• Tosca M, Ciprandi G, Passalacqua G, et al. Cetirizine reduces conjunctival nonspecific hyperreactivity in children with mite allergy. J Investig Allergol Clin Immunol 1998;8:23-6
   PubMedGoogle Scholar
• Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996;109:272-6
   PubMedGoogle Scholar
• Passalacqua G, Ciprandi G, Pasquali M, et al. An update on the asthma-rhinitis link. Curr Opin Allergy Clin Immunol 2004;4:177-83
   PubMed Web of Science ®Google Scholar
• Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset of asthma. J Allergy Clin Immunol 2002;109:419-25
   PubMed Web of Science ®Google Scholar
• Lee CF, Sun HL, Lu KH, et al. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis. Pediatr Allergy Immunol 2009;20:493-9
   PubMed Web of Science ®Google Scholar
• Klimek L. Potential of levocetirizine in the relief of nasal congestion. Int J Clin Pract 2005;59(6):721-9
   PubMedGoogle Scholar
• Müller UR, Jutel M, Reimers A, et al. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy. J Allergy Clin Immunol 2008;122(5):1001-7
   PubMedGoogle Scholar
• Day JH, Briscoe MP, Ratz JD. Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the environmental exposure unit. Allergy Asthma Proc 2008;29(3):304-12
   PubMed Web of Science ®Google Scholar
• Patel P, Patel D. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. Ann Allergy Asthma Immunol 2008;101(3):287-94
   PubMed Web of Science ®Google Scholar
• de Blic J, Wahn U, Billard E, et al. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pedriatr Allergy Immunol 2005;16(3):267-75
   PubMed Web of Science ®Google Scholar
• Potter PC, for the Paediatric Levocetirizine Study Group. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol 2005;95:175-80
   PubMed Web of Science ®Google Scholar
• Monroe E. Review of H1 antihistamines in the treatment of chronic urticaria. Cutis 2005;76:118-26
   PubMed Web of Science ®Google Scholar
• Potter PC, Kapp A, Maurer M, et al. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy 2009;64(4):596-604
   PubMed Web of Science ®Google Scholar
• Kapp A, Wedi B. Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine. J Drug Dermatol 2004;3:632-9
   PubMedGoogle Scholar
• Nettis E, Colanardi MC, Barra L, et al. Levocetirizine in the treatment of chronica idiopathic: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2006;154:533-8
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Van Hammée G, et al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med 2006;100(10):1706-15
   PubMed Web of Science ®Google Scholar
• Klimek L. Long-term treatment of persistent allergic rhinitis with levocetirizine: improvements in activity and sleep items of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Allergy Clin Immunol Int J World Allergy Org 2007;19:4-10
   Google Scholar
• Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 2006;45(4):469-74
   PubMed Web of Science ®Google Scholar
• Yap YG, Camm AJ. Potential cardiac toxicity of H1-antihistamines. Clin Allergy Immunol 2002;17:389-419
   PubMedGoogle Scholar
• Verster JC, Volkerts ER, van Oosterwijck AW, et al. Acute and subchronic effects of levocetirizine, cetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol 2003;111:623-7
   PubMed Web of Science ®Google Scholar
• McDonald K, Trick L, Boyle J. Sedation and antihistamines: an update. review of inter-drug differences using proportional impairmente ratios. Hum Psychopharmacol Clin Exp 2008;23(7):555-7
   PubMed Web of Science ®Google Scholar
• Hulhoven R, Rosillon D, Letiexhe M, et al. Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. Eur J Pharmacol 2007;63:1011-7
   Google Scholar
• Grimfeld A, Holgate ST, Canonica GW, et al. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. Clin Exp Allergy 2004;34(11):1665-72
   PubMed Web of Science ®Google Scholar
• Simons FE. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. J Allergy Clin Immunol 1999;104(2 Pt 1):433-40
   PubMed Web of Science ®Google Scholar
• Lee DK, Gardiner M, Haggart K, et al. Comparative effects of desloratadine, fexofenadine and levocetirizine on nasal adenosine monophosphate in patients with perennial allergic rhinitis. Clin Exp Allergy 2004;34:650-3
   PubMed Web of Science ®Google Scholar
• Patil PA, Kothekar MA. Development of safer molecules through chirality. Indian J Med Sci 2006;60:427-37
   PubMedGoogle Scholar
• Bachert C. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clin Ther 2009;31(5):921-44
   PubMed Web of Science ®Google Scholar